Ignite Creation Date:
2024-05-06 @ 1:38 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04074096
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2019-08-26
Brief Title:
Binimetinib Encorafenib Pembrolizumab - Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis
Sponsor:
UNICANCER
Organization:
UNICANCER
Organization Data
Organization:
UNICANCER
Class:
OTHER
Study ID:
RAD06 - UC-01071810
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNICANCER
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| European Association of Dermato Oncology | UNKNOWN |
| Pierre Fabre Medicament | INDUSTRY |
| Merck Sharp Dohme LLC | INDUSTRY |